Your browser version may not work well with NCBI's Web applications. More information here...
1: Breast Cancer Res. 2003;5(6):289-93. Epub 2003 Sep 5.
Related Articles, Links
Click here to read Click here to read
American Society for Clinical Oncology 39th Annual Meeting, Chicago, Illinois, USA, 31 May to 3 June 2003: breast cancer neoadjuvant and adjuvant chemotherapy--prognostic and predictive markers.

Earl H; American Society for Clinical Oncology.

Department of Oncology, Box 193, University of Cambridge, Addenbrookes Hospital, Cambridge, UK. hme22@cam.ac.uk

The annual American Society of Clinical Oncology congress is the largest forum for cancer professionals in the world, promoting new developments in cancer medicine. A wide spectrum of subjects relevant to breast cancer research and treatment was covered in this year's meeting, including chemotherapy in the neoadjuvant and adjuvant settings, molecular and gene profiling studies, and use of more conventional prognostic and predictive markers of outcome. This report discusses some of the highlights in translational and clinical aspects of early breast cancer management presented at the meeting.

Publication Types:
PMID: 14580243 [PubMed - indexed for MEDLINE]

PMCID: PMC314407